Clinical trial · Interventional
Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma
NCT01974284CI-TRIAL-00041899terminatedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Lack of patient enrollment
Summary
Brief summary (as posted)
We assess the effectiveness of percutaneous ethanol ablation for the treatment of thyroid cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Papillary Thyroid Cancer | Thyroid Gland Papillary Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| percutaneous ethanol ablation | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- percutaneous ethanol ablation
- description
- The experimental group of the study is comprised of patients that will undergo percutaneous ethanol ablation for the management of papillary thyroid microcarcinoma.
- interventionNames
- Drug: percutaneous ethanol ablation
Primary outcomes (2)
- measure
- Disease-free
- timeFrame
- 5 years
- description
- Primary endpoint of the study consists of the oncological outcome, which includes the disease-free status of the patients.
- measure
- Overall Survival
- timeFrame
- 5 years
- description
- Primary endpoint of the study consists of the oncological outcome, which includes the overall survival of the patients.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 years and older * Diagnosis: single, cytology-proven papillary thyroid carcinoma measuring 1 cm or less in diameter (microcarcinoma, T1a), without visible extrathyroidal extension, and with negative central and lateral neck lymph nodes by ultrasound Exclusion Criteria: * Patient refusal to participate * History of prior thyroid or parathyroid surgery * Previous recurrent laryngeal nerve injury * Inability to make decisions or comply with follow up * Co-existing indication for thyroidectomy * Aggressive cytological or molecular features * Multifocal papillary thyroid carcinoma * Pregnant or breast-feeding * Anatomically unfavorable location of the tumor (proximity to recurrent laryngeal nerve or trachea) * Documented or suspected distant metastasis * History of radiation to neck or face * Family history of thyroid cancer
References
Publications (0)
Data not yet available
No reference posted for this study.